Key facts
- ObjectiveHealth’s last known valuation is $87.5M (Nov 2022).
- It has raised $68.5M across 2 recorded rounds; the latest was Early Stage VC ($47.2M) in Mar 2025.
- Notable investors include Vitruvian Partners, BIP Ventures, NueCura Partners.
- ObjectiveHealth has filed 2 Form Ds with the SEC since 2022, most recently Oct 2025 ($47.2M sold to 6 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for ObjectiveHealth
Funding rounds
2 roundsAbout ObjectiveHealth
Developer of a clinical research site network intended to improve patient outcomes at the point of care. The company offers tools needed to integrate clinical trials into practice and utilizes proprietary technology, and processes to deliver significant advances in the conduct of research, enabling physicians and healthcare organizations to establish advanced infrastructure for research programs and to gain access to trials within their community.
- Sector
- Healthcare
- HQ
- Franklin, TN, United States
- Founded
- 2018
- Employees
- 160
- Website
- objective.health/
- Ownership
- Privately Held (backing)
ObjectiveHealth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ObjectiveHealth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ObjectiveHealth in its N-PORT filings yet. We sweep new filings monthly.